Ya-jun Gu1, Peng Ge, Yun Mu, Jin-hai Lu, Fang Zheng, Xu-guo Sun. 1. School of Medical Laboratory, Tianjin Medical University, Tianjin 300203, China; Department of Clinical Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; Department of Clinical Laboratory, Tianjin Children's Hospital, Tianjin 300074, China.
Abstract
OBJECTIVE: Our aim was to investigate clinical and laboratory characteristics of osteoarthritic patients who had amyloid deposition in their knee joints. METHODS: Synovial membranes were obtained from 36 patients with knee osteoarthritis (OA) who underwent joint replacement surgery. From this sample, the diagnosis of amyloid was determined by Congo red staining, which demonstrated apple-green birefringence under a polarized microscope. All synovial membranes were immunohistochemically characterized for the expressions of amyloid immunoglobulin light chain (AL-κ and AL-λ), serum amyloid-A (SAA), amyloidogenic transthyretin (ATTR), and amyloidogenic β2-microglobulin (Aβ2M). Matrix-assisted laser desorption-ionizaton/time of flight mass spectrometry (MALDI-TOF MS) was used to analyze transthyretin (TTR) isoforms in the serum of each patient. RESULTS: Nine cases (25%) were found to be amyloid-positive. Immunohistochemically, eight cases (88.9%) had ATTR deposition, and one sample (11.1%) was shown to be AL-κ-positive. MALDI-TOF MS identified that the TTR in the serum of the patients was unmodified wild-type TTR, TTR-Cys-S-S-Cys, and TTR-Cys-S-S-CysGly. The age at surgery and the disease duration were significantly higher in the ATTR-positive group than in the ATTR-negative group. Knee score and function score were significantly lower in the ATTR-positive group than in the ATTR-negative group. CONCLUSIONS: Amyloid deposition in synovial membranes of OA patients was found to be ATTR and AL-κ. TTR in the serum of the patients was unmodified wild-type TTR together with two isoforms. The high age at surgery, long disease duration, and a deteriorated knee function were associated with ATTR amyloid deposition in the osteoarthritic knee joints.
OBJECTIVE: Our aim was to investigate clinical and laboratory characteristics of osteoarthritic patients who had amyloid deposition in their knee joints. METHODS: Synovial membranes were obtained from 36 patients with knee osteoarthritis (OA) who underwent joint replacement surgery. From this sample, the diagnosis of amyloid was determined by Congo red staining, which demonstrated apple-green birefringence under a polarized microscope. All synovial membranes were immunohistochemically characterized for the expressions of amyloid immunoglobulin light chain (AL-κ and AL-λ), serum amyloid-A (SAA), amyloidogenic transthyretin (ATTR), and amyloidogenic β2-microglobulin (Aβ2M). Matrix-assisted laser desorption-ionizaton/time of flight mass spectrometry (MALDI-TOF MS) was used to analyze transthyretin (TTR) isoforms in the serum of each patient. RESULTS: Nine cases (25%) were found to be amyloid-positive. Immunohistochemically, eight cases (88.9%) had ATTR deposition, and one sample (11.1%) was shown to be AL-κ-positive. MALDI-TOF MS identified that the TTR in the serum of the patients was unmodified wild-type TTR, TTR-Cys-S-S-Cys, and TTR-Cys-S-S-CysGly. The age at surgery and the disease duration were significantly higher in the ATTR-positive group than in the ATTR-negative group. Knee score and function score were significantly lower in the ATTR-positive group than in the ATTR-negative group. CONCLUSIONS: Amyloid deposition in synovial membranes of OA patients was found to be ATTR and AL-κ. TTR in the serum of the patients was unmodified wild-type TTR together with two isoforms. The high age at surgery, long disease duration, and a deteriorated knee function were associated with ATTR amyloid deposition in the osteoarthritic knee joints.
Authors: T M El Mansoury; B P C Hazenberg; S A El Badawy; A H Ahmed; J Bijzet; P C Limburg; M H van Rijswijk Journal: Ann Rheum Dis Date: 2002-01 Impact factor: 19.103
Authors: T Kuroda; N Tanabe; M Sakatsume; S Nozawa; T Mitsuka; H Ishikawa; C T Tohyama; K Nakazono; A Murasawa; M Nakano; F Gejyo Journal: Clin Rheumatol Date: 2002-05 Impact factor: 2.980
Authors: Jean D Sipe; Merrill D Benson; Joel N Buxbaum; Shu-ichi Ikeda; Giampaolo Merlini; Maria J M Saraiva; Per Westermark Journal: Amyloid Date: 2012-11-01 Impact factor: 7.141
Authors: Yukio Akasaki; Natàlia Reixach; Tokio Matsuzaki; Oscar Alvarez-Garcia; Merissa Olmer; Yukihide Iwamoto; Joel N Buxbaum; Martin K Lotz Journal: Arthritis Rheumatol Date: 2015-05 Impact factor: 10.995
Authors: Tokio Matsuzaki; Yukio Akasaki; Merissa Olmer; Oscar Alvarez-Garcia; Natalia Reixach; Joel N Buxbaum; Martin K Lotz Journal: Aging Cell Date: 2017-09-22 Impact factor: 9.304
Authors: Austin E Wininger; Brian M Phelps; Jessica T Le; Joshua D Harris; Barry H Trachtenberg; Shari R Liberman Journal: BMC Musculoskelet Disord Date: 2021-01-08 Impact factor: 2.362